li_item_id stringlengths 7 30 | drug_name stringlengths 4 169 | li_drug_name stringlengths 4 169 ⌀ | li_form stringlengths 8 210 ⌀ | schedule_form stringlengths 21 261 ⌀ | brand_name stringlengths 3 88 ⌀ | program_code stringclasses 17
values | pbs_code stringlengths 3 6 | benefit_type_code stringclasses 4
values | caution_indicator stringclasses 2
values | note_indicator stringclasses 2
values | manner_of_administration stringclasses 25
values | maximum_prescribable_pack float64 0.08 200 ⌀ | maximum_quantity_units float64 1 2.1k ⌀ | number_of_repeats float64 0 140 ⌀ | organisation_id float64 7 2.49k ⌀ | manufacturer_code stringclasses 226
values | pack_size float64 1 1k ⌀ | pricing_quantity float64 1 1k ⌀ | pack_not_to_be_broken_ind stringclasses 2
values | claimed_price float64 0.75 2.53M ⌀ | determined_price float64 0.75 2.53M ⌀ | determined_qty stringclasses 2
values | safety_net_resupply_rule_days float64 4 50 ⌀ | safety_net_resup_rule_cnt_ind stringclasses 2
values | extemporaneous_indicator stringclasses 2
values | extemporaneous_standard stringclasses 14
values | doctors_bag_group_id float64 1 62 ⌀ | section100_only_indicator stringclasses 2
values | doctors_bag_only_indicator stringclasses 2
values | brand_substitution_group_id float64 14.6k 29.7k ⌀ | brand_substitution_group_code stringclasses 2
values | supply_only_indicator stringclasses 2
values | supply_only_date stringclasses 9
values | non_effective_date stringclasses 3
values | weighted_avg_disclosed_price float64 | originator_brand_indicator stringclasses 2
values | paper_med_chart_eligible_ind stringclasses 2
values | elect_med_chart_eligible_ind stringclasses 2
values | hsptl_med_chart_eligible_ind stringclasses 2
values | paper_med_chart_duration float64 4 4 ⌀ | elect_med_chart_duration float64 6 6 ⌀ | hsptl_chart_acute_duration float64 12 12 ⌀ | hsptl_chart_sub_acute_duration float64 12 12 ⌀ | hsptl_chart_chronic_duration float64 12 12 ⌀ | pack_content float64 1 20k ⌀ | vial_content float64 1 15k ⌀ | infusible_indicator stringclasses 2
values | unit_of_measure stringclasses 6
values | continued_dispensing_flag stringclasses 2
values | continued_dispensing_emergency stringclasses 1
value | maximum_amount float64 2 30k ⌀ | formulary stringclasses 3
values | water_added_ind stringclasses 2
values | section_19a_expiry_date stringclasses 16
values | container_fee_type stringclasses 2
values | policy_applied_imdq60_base_flag stringclasses 2
values | policy_applied_imdq60_flag stringclasses 2
values | policy_applied_bio_sim_up_flag stringclasses 1
value | policy_applied_indig_phar_flag stringclasses 2
values | therapeutic_exemption_indicator stringclasses 2
values | premium_exemption_group_id float64 1.34k 1.34k ⌀ | doctors_bag_group_title stringclasses 1
value | therapeutic_group_id float64 1.34k 1.34k ⌀ | therapeutic_group_title stringclasses 1
value | advanced_notice_date stringclasses 3
values | supply_only_end_date stringclasses 8
values | first_listed_date stringdate 1991-08-01 00:00:00 2025-05-01 00:00:00 ⌀ | legal_unar_ind stringclasses 2
values | legal_car_ind stringclasses 2
values | schedule_code int64 3.67k 3.67k |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10176N_7861_287_15553_51625 | Doxycycline | Doxycycline | Tablet 100 mg (as hyclate) | doxycycline 100 mg tablet, 21 | APX-Doxycycline | GE | 10176N | R | N | Y | ORAL | 1 | 21 | 0 | 72 | TX | 21 | 7 | N | 7.5 | 2.5 | N | 4 | N | N | null | null | N | N | 15,555 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2021-05-01 | N | N | 3,671 |
10177P_12557_15634_35269_48641 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Co-Senna | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 29 | PP | 90 | 90 | N | 5.47 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-12-01 | N | N | 3,671 |
10177P_12557_15634_35269_48642 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Colaxsen | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 70 | AS | 90 | 90 | N | 5.47 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-12-01 | N | N | 3,671 |
10177P_12557_15634_35269_48643 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Coloxyl with Senna | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 70 | LN | 90 | 90 | N | 5.47 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-12-01 | N | N | 3,671 |
10177P_12557_15634_35269_48644 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Chemists'' Own Laxative with Senna | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 1,081 | RW | 90 | 90 | N | 5.47 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-12-01 | N | N | 3,671 |
10177P_12557_15634_35269_48645 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Trust Coloxease | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 87 | CR | 90 | 90 | N | 5.47 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2019-12-01 | N | N | 3,671 |
10177P_12557_15634_35269_54944 | docusate + sennoside B | Docusate with sennoside B | Tablet containing docusate sodium 50 mg with sennoside B 8 mg | docusate sodium 50 mg + sennoside B 8 mg tablet, 90 | Pharmacy Action Colox-Senna | R1 | 10177P | U | N | N | ORAL | 1 | 90 | 2 | 145 | HQ | 90 | 90 | N | 5.43 | 5.43 | N | 4 | N | N | null | null | N | N | 23,582 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2022-12-01 | N | N | 3,671 |
10178Q_15190_35165_35168_35170 | Midazolam | Midazolam | Injection 5 mg (as hydrochloride) in 1 mL | midazolam 5 mg/mL injection, 10 x 1 mL ampoules | Pfizer Australia Pty Ltd | DB | 10178Q | U | N | N | INJECTION | 1 | 10 | 0 | 69 | PF | 10 | 10 | N | 24.54 | 24.54 | N | 4 | N | N | null | 53 | N | N | null | null | N | null | null | null | N | N | N | N | null | null | null | null | null | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10180T_14432_32082_32107_32178 | Brentuximab vedotin | Brentuximab vedotin | Powder for I.V. infusion 50 mg | brentuximab vedotin 50 mg injection, 1 vial | Adcetris | IN | 10180T | A | N | Y | INJECTION | null | null | 11 | 104 | TK | 1 | 1 | N | 4,422.25 | 4,422.25 | Y | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 50 | 50 | Y | mg | N | N | 200 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10181W_15096_1181_33429_33431 | Escitalopram | Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | escitalopram 20 mg/mL oral liquid, 15 mL | Lexapro | GE | 10181W | R | N | N | ORAL | 1 | 1 | 5 | 131 | LU | 1 | 1 | Y | 24.15 | 24.15 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10182X_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HS | 10182X | A | Y | Y | INJECTION | 1 | 1 | 0 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10183Y_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HB | 10183Y | A | Y | Y | INJECTION | 1 | 1 | 5 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10184B_11574_1167_5317_38268 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Inflectra | HS | 10184B | A | N | Y | INJECTION | 1 | 1 | 0 | 69 | PF | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,383 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-12-01 | N | Y | 3,671 |
10184B_11574_1167_5317_41027 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Renflexis | HS | 10184B | A | N | Y | INJECTION | 1 | 1 | 0 | 1,829 | OQ | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,383 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-08-01 | N | Y | 3,671 |
10184B_11574_1167_5317_6278 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Remicade | HS | 10184B | A | N | Y | INJECTION | 1 | 1 | 0 | 63 | JC | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,383 | a | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10185C_14418_1334_32348_32350 | high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 200 mL, 32 (KetoCal 4:1 LQ) | high fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate (4:1 ratio long chain fat to carbohydrate plus protein) oral liquid, 32 x 200 mL cartons | KetoCal 4:1 LQ | GE | 10185C | R | N | Y | ORAL | 5 | 5 | 5 | 152 | SB | 1 | 1 | N | 166.61 | 166.61 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10187E_14874_33822_33825_33827 | Umeclidinium | Umeclidinium | Powder for oral inhalation in breath actuated device 62.5 micrograms (as bromide) per dose, 30 doses | umeclidinium 62.5 microgram/actuation inhalation: powder for, 30 actuations | Incruse Ellipta | GE | 10187E | R | N | Y | INHALATION_BY_MOUTH | 1 | 1 | 5 | 66 | GK | 1 | 1 | Y | 42.7 | 42.7 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10188F_14342_32217_32221_32223 | umeclidinium + vilanterol | Umeclidinium with vilanterol | Powder for oral inhalation in breath actuated device containing umeclidinium 62.5 micrograms (as bromide) with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | umeclidinium 62.5 microgram/actuation + vilanterol 25 microgram/actuation powder for inhalation, 30 actuations | Anoro Ellipta 62.5/25 | GE | 10188F | S | N | Y | INHALATION_BY_MOUTH | 1 | 1 | 5 | 66 | GK | 1 | 1 | Y | 68.38 | 68.38 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | CDL | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10189G_15095_1357_33589_33591 | triglycerides long chain with glucose polymer | Triglycerides, long chain with glucose polymer | Oral liquid 200 mL, 27 (Sno-Pro) | triglycerides long chain with glucose polymer oral liquid, 27 x 200 mL cartons | Sno-Pro | GE | 10189G | R | N | N | ORAL | 2 | 2 | 5 | 152 | SB | 1 | 1 | N | 49.53 | 49.53 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10190H_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HB | 10190H | A | Y | Y | INJECTION | 1 | 1 | 4 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10191J_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HB | 10191J | A | Y | Y | INJECTION | 1 | 1 | 0 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10192K_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HS | 10192K | A | Y | Y | INJECTION | 1 | 1 | 4 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10194M_15154_32180_32181_32185 | Eculizumab | Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | eculizumab 300 mg/30 mL injection, 30 mL vial | Soliris | HS | 10194M | A | Y | Y | INJECTION | 1 | 1 | 5 | 599 | XI | 1 | 1 | N | 5,358.6 | 5,358.6 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10195N_15093_34991_34994_34996 | glycine with carbohydrate | Glycine with carbohydrate | Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500) | glycine with carbohydrate containing 500 mg glycine powder for oral liquid, 30 x 4 g sachets | Glycine500 | GE | 10195N | R | N | N | ORAL | 4 | 4 | 5 | 126 | VF | 1 | 1 | N | 102.82 | 102.82 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | N | 3,671 |
10196P_11574_1167_5317_38268 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Inflectra | HB | 10196P | A | N | Y | INJECTION | 1 | 1 | 0 | 69 | PF | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,398 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-12-01 | N | Y | 3,671 |
10196P_11574_1167_5317_41027 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Renflexis | HB | 10196P | A | N | Y | INJECTION | 1 | 1 | 0 | 1,829 | OQ | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,398 | a | N | null | null | null | N | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2017-08-01 | N | Y | 3,671 |
10196P_11574_1167_5317_6278 | Infliximab | Infliximab | Powder for I.V. infusion 100 mg | infliximab 100 mg injection, 1 vial | Remicade | HB | 10196P | A | N | Y | INJECTION | 1 | 1 | 0 | 63 | JC | 1 | 1 | N | 186.16 | 186.16 | N | 4 | N | N | null | null | N | N | 20,398 | a | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2014-12-01 | N | Y | 3,671 |
10198R_11642_1313_5748_38851 | Voriconazole | Voriconazole | Tablet 200 mg | voriconazole 200 mg tablet, 56 | Voriconazole Sandoz | GE | 10198R | A | N | Y | ORAL | 1 | 56 | 0 | 90 | SZ | 56 | 56 | N | 168.54 | 168.54 | N | 4 | N | N | null | null | N | N | 20,447 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-02-01 | N | N | 3,671 |
10198R_11642_1313_5748_39445 | Voriconazole | Voriconazole | Tablet 200 mg | voriconazole 200 mg tablet, 56 | Vttack | GE | 10198R | A | N | Y | ORAL | 1 | 56 | 0 | 142 | AF | 56 | 56 | N | 168.54 | 168.54 | N | 4 | N | N | null | null | N | N | 20,447 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-03-01 | N | N | 3,671 |
10198R_11642_1313_5748_41462 | Voriconazole | Voriconazole | Tablet 200 mg | voriconazole 200 mg tablet, 56 | Vzole | GE | 10198R | A | N | Y | ORAL | 1 | 56 | 0 | 1,081 | RW | 56 | 56 | N | 168.54 | 168.54 | N | 4 | N | N | null | null | N | N | 20,447 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2016-12-01 | N | N | 3,671 |
101H____ | Acetic Acid (33 per cent) | null | null | null | null | EP | 101H | U | N | N | null | null | null | null | null | null | null | null | N | null | null | N | null | N | Y | BP | null | N | N | null | null | N | null | null | null | N | N | N | N | null | null | null | null | null | null | null | N | null | N | N | null | null | N | null | null | N | N | N | N | N | null | null | null | null | null | null | null | N | N | 3,671 |
10201X_15315_34257_34261_34264 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 | Rosuzet Composite Pack | GE | 10201X | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AL | 1 | 1 | Y | 16.65 | 13.88 | N | 20 | Y | N | null | null | N | N | 22,395 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10201X_15315_34257_34261_45176 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 | Ezalo Composite Pack 10mg+20mg | GE | 10201X | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AF | 1 | 1 | Y | 13.88 | 13.88 | N | 20 | Y | N | null | null | N | N | 22,395 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2018-06-01 | N | N | 3,671 |
10201X_15315_34257_34261_56436 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 | Pharmacor Ezetimibe Rosuvastatin Composite Pack | GE | 10201X | U | N | Y | ORAL | 1 | 1 | 5 | 87 | CR | 1 | 1 | Y | 13.88 | 13.88 | N | 20 | Y | N | null | null | N | N | 22,395 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2023-07-01 | N | N | 3,671 |
10201X_15315_34257_34261_59702 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60 | Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg | GE | 10201X | U | N | Y | ORAL | 1 | 1 | 5 | 90 | SZ | 1 | 1 | Y | 13.88 | 13.88 | N | 20 | Y | N | null | null | N | N | 22,395 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2025-03-01 | N | N | 3,671 |
10202Y_15176_33050_33061_33063 | Empagliflozin | Empagliflozin | Tablet 25 mg | empagliflozin 25 mg tablet, 30 | Jardiance | GE | 10202Y | S | N | Y | ORAL | 1 | 30 | 5 | 71 | BY | 30 | 30 | N | 39.22 | 39.22 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10203B_15310_15575_35561_35565 | Estradiol | Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | estradiol 10 microgram modified release pessary, 18 | Vagifem Low | GE | 10203B | U | N | Y | VAGINAL | 1 | 18 | 2 | 51 | NO | 18 | 18 | N | 15.4 | 15.4 | N | 4 | N | N | null | null | N | N | 27,217 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10203B_15310_15575_35561_55589 | Estradiol | Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | estradiol 10 microgram modified release pessary, 18 | Estro-Pess | GE | 10203B | U | N | Y | VAGINAL | 1 | 18 | 2 | 70 | AS | 18 | 18 | N | 15.4 | 15.4 | N | 4 | N | N | null | null | N | N | 27,217 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2023-04-01 | N | N | 3,671 |
10204C_15312_34257_34269_34272 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60 | Rosuzet Composite Pack | GE | 10204C | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AL | 1 | 1 | Y | 13.42 | 10.75 | N | 20 | Y | N | null | null | N | N | 22,399 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10204C_15312_34257_34269_45178 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60 | Ezalo Composite Pack 10mg+5mg | GE | 10204C | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AF | 1 | 1 | Y | 10.75 | 10.75 | N | 20 | Y | N | null | null | N | N | 22,399 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2018-06-01 | N | N | 3,671 |
10204C_15312_34257_34269_59711 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60 | Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg | GE | 10204C | U | N | Y | ORAL | 1 | 1 | 5 | 90 | SZ | 1 | 1 | Y | 10.75 | 10.75 | N | 20 | Y | N | null | null | N | N | 22,399 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2025-03-01 | N | N | 3,671 |
10205D_12148_590_35583_35585 | testosterone undecanoate | Testosterone | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | testosterone undecanoate 1 g/4 mL modified release injection, 4 mL vial | Reandron 1000 | GE | 10205D | A | N | Y | INJECTION | 1 | 1 | 1 | 70 | AS | 1 | 1 | N | 75.31 | 75.31 | N | 20 | Y | N | null | null | N | N | 28,648 | a | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10205D_12148_590_35583_57804 | testosterone undecanoate | Testosterone | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | testosterone undecanoate 1 g/4 mL modified release injection, 4 mL vial | Testosterone ADVZ 1000 | GE | 10205D | A | N | Y | INJECTION | 1 | 1 | 1 | 83 | BZ | 1 | 1 | N | 75.31 | 75.31 | N | 20 | Y | N | null | null | N | N | 28,648 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-06-01 | N | N | 3,671 |
10205D_12148_590_35583_58579 | testosterone undecanoate | Testosterone | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | testosterone undecanoate 1 g/4 mL modified release injection, 4 mL vial | REJUNON 1000 | GE | 10205D | A | N | Y | INJECTION | 1 | 1 | 1 | 1,040 | JU | 1 | 1 | N | 75.31 | 75.31 | N | 20 | Y | N | null | null | N | N | 28,648 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-08-01 | N | N | 3,671 |
10205D_12148_590_35583_58580 | testosterone undecanoate | Testosterone | I.M. injection containing testosterone undecanoate 1,000 mg in 4 mL | testosterone undecanoate 1 g/4 mL modified release injection, 4 mL vial | Gonadron | GE | 10205D | A | N | Y | INJECTION | 1 | 1 | 1 | 24 | RA | 1 | 1 | N | 75.31 | 75.31 | N | 20 | Y | N | null | null | N | N | 28,648 | a | N | null | null | null | N | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-08-01 | N | N | 3,671 |
10206E_15132_33050_33058_33060 | Empagliflozin | Empagliflozin | Tablet 10 mg | empagliflozin 10 mg tablet, 30 | Jardiance | GE | 10206E | S | N | Y | ORAL | 1 | 30 | 5 | 71 | BY | 30 | 30 | N | 39.02 | 39.02 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10207F_15316_34257_34265_34268 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 | Rosuzet Composite Pack | GE | 10207F | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AL | 1 | 1 | Y | 16.46 | 13.59 | N | 20 | Y | N | null | null | N | N | 22,369 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10207F_15316_34257_34265_45177 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 | Ezalo Composite Pack 10mg+40mg | GE | 10207F | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AF | 1 | 1 | Y | 13.59 | 13.59 | N | 20 | Y | N | null | null | N | N | 22,369 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2018-06-01 | N | N | 3,671 |
10207F_15316_34257_34265_56437 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 | Pharmacor Ezetimibe Rosuvastatin Composite Pack | GE | 10207F | U | N | Y | ORAL | 1 | 1 | 5 | 87 | CR | 1 | 1 | Y | 13.59 | 13.59 | N | 20 | Y | N | null | null | N | N | 22,369 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2023-07-01 | N | N | 3,671 |
10207F_15316_34257_34265_59708 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60 | Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg | GE | 10207F | U | N | Y | ORAL | 1 | 1 | 5 | 90 | SZ | 1 | 1 | Y | 13.59 | 13.59 | N | 20 | Y | N | null | null | N | N | 22,369 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2025-03-01 | N | N | 3,671 |
10208G_15314_34257_34258_34273 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 | Rosuzet Composite Pack | GE | 10208G | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AL | 1 | 1 | Y | 14.81 | 12.04 | N | 20 | Y | N | null | null | N | N | 22,388 | a | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2015-01-01 | N | N | 3,671 |
10208G_15314_34257_34258_45175 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 | Ezalo Composite Pack 10mg+10mg | GE | 10208G | U | N | Y | ORAL | 1 | 1 | 5 | 142 | AF | 1 | 1 | Y | 12.04 | 12.04 | N | 20 | Y | N | null | null | N | N | 22,388 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2018-06-01 | N | N | 3,671 |
10208G_15314_34257_34258_56435 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 | Pharmacor Ezetimibe Rosuvastatin Composite Pack | GE | 10208G | U | N | Y | ORAL | 1 | 1 | 5 | 87 | CR | 1 | 1 | Y | 12.04 | 12.04 | N | 20 | Y | N | null | null | N | N | 22,388 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2023-07-01 | N | N | 3,671 |
10208G_15314_34257_34258_59714 | ezetimibe (&) rosuvastatin | Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60 | Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg | GE | 10208G | U | N | Y | ORAL | 1 | 1 | 5 | 90 | SZ | 1 | 1 | Y | 12.04 | 12.04 | N | 20 | Y | N | null | null | N | N | 22,388 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | Y | N | null | F2 | N | null | null | Y | N | N | N | N | null | null | null | null | null | null | 2025-03-01 | N | N | 3,671 |
10209H_15372_15590_35937_59164 | Lidocaine | Lidocaine | Injection containing lidocaine hydrochloride monohydrate 50 mg in 5 mL | lidocaine hydrochloride monohydrate 1% (50 mg/5 mL) injection, 5 x 5 mL ampoules | LIGNOCAINE INJECTION (BRIDGEWEST) | DB | 10209H | U | N | N | INJECTION | 1 | 5 | 0 | 2,289 | WZ | 5 | 5 | N | 34.82 | 34.82 | N | 4 | N | N | null | 54 | N | N | null | null | N | null | null | null | N | N | N | N | null | null | null | null | null | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2024-10-01 | N | N | 3,671 |
10211K_15390_35930_35931_35934 | mifepristone (&) misoprostol | Mifepristone and misoprostol | Pack containing 1 tablet mifepristone 200 mg and 4 tablets misoprostol 200 micrograms | mifepristone 200 mg tablet [1] (&) misoprostol 200 microgram tablet [4], 1 pack | MS-2 Step | GE | 10211K | S | N | Y | ORAL | 1 | 1 | 0 | 437 | XH | 1 | 1 | Y | 338.61 | 338.61 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2015-02-01 | N | N | 3,671 |
10212L_15012_34444_34488_34490 | Peginterferon beta-1a | Peginterferon beta-1a | Single use injection pen containing 125 micrograms in 0.5 mL | peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices | Plegridy | GE | 10212L | S | N | Y | INJECTION | 1 | 2 | 4 | 40 | BD | 2 | 2 | N | 555.47 | 555.47 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10213M_16051_36019_36022_36024 | Phytomenadione | Phytomenadione | Injection 10 mg in 1 mL | phytomenadione 10 mg/mL injection, 5 x 1 mL ampoules | Konakion MM | DB | 10213M | U | N | N | INJECTION_ORAL | 1 | 5 | 0 | 817 | PB | 5 | 5 | N | 11.32 | 11.32 | N | 4 | N | N | null | 55 | N | Y | null | null | N | null | null | null | Y | N | N | N | null | null | null | null | null | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10214N_16010_413_34845_34847 | Mercaptopurine | Mercaptopurine | Oral suspension containing mercaptopurine monohydrate 20 mg per mL, 100 mL | mercaptopurine monohydrate 20 mg/mL oral liquid, 100 mL | Allmercap | GE | 10214N | U | N | N | ORAL | 1 | 1 | 2 | 108 | LM | 1 | 1 | Y | 330.59 | 330.59 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10218T_15030_34444_34559_34567 | Peginterferon beta-1a | Peginterferon beta-1a | Pack containing single use injection pens containing 63 micrograms in 0.5 mL and 94 micrograms in 0.5 mL | peginterferon beta-1a 63 microgram/0.5 mL injection [0.5 mL pen device] (&) peginterferon beta-1a 94 microgram/0.5 mL injection [0.5 mL pen device], 1 pack | Plegridy | GE | 10218T | S | N | Y | INJECTION | 1 | 1 | 0 | 40 | BD | 1 | 1 | Y | 555.47 | 555.47 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | null | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10219W_15253_1186_33746_33748 | Aripiprazole | Aripiprazole | Powder for injection 400 mg (as monohydrate) with diluent | aripiprazole 400 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack | Abilify Maintena | GE | 10219W | S | N | N | INJECTION | 1 | 1 | 5 | 131 | LU | 1 | 1 | N | 315.46 | 315.46 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10220X_15012_34444_34488_34490 | Peginterferon beta-1a | Peginterferon beta-1a | Single use injection pen containing 125 micrograms in 0.5 mL | peginterferon beta-1a 125 microgram/0.5 mL injection, 2 x 0.5 mL pen devices | Plegridy | GE | 10220X | S | N | Y | INJECTION | 1 | 2 | 5 | 40 | BD | 2 | 2 | N | 555.47 | 555.47 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10224D_15252_1186_33742_33745 | Aripiprazole | Aripiprazole | Powder for injection 300 mg (as monohydrate) with diluent | aripiprazole 300 mg modified release injection [1 vial] (&) inert substance diluent [2 mL vial], 1 pack | Abilify Maintena | GE | 10224D | S | N | N | INJECTION | 1 | 1 | 5 | 131 | LU | 1 | 1 | N | 252.36 | 252.36 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-03-01 | N | N | 3,671 |
10226F_10923_1315_5752_6991 | Sorafenib | Sorafenib | Tablet 200 mg (as tosilate) | sorafenib 200 mg tablet, 60 | Nexavar | GE | 10226F | A | N | Y | ORAL | 2 | 120 | 2 | 30 | BN | 60 | 60 | N | 1,993.7 | 1,993.7 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10228H_14792_33253_33256_33258 | Alemtuzumab | Alemtuzumab | Solution concentrate for I.V. infusion 12 mg in 1.2 mL | alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial | Lemtrada | HB | 10228H | S | N | Y | INJECTION | 5 | 5 | 0 | 42 | GZ | 1 | 1 | N | 10,283.09 | 10,283.09 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10229J_7319_1207_5454_6567 | Iron sucrose | Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | iron (as sucrose) 100 mg/5 mL injection, 5 x 5 mL ampoules | Venofer | GE | 10229J | U | N | N | INJECTION | 1 | 5 | 0 | 497 | VL | 5 | 5 | N | 24.25 | 24.25 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10230K_14992_34275_34278_34280 | Sucroferric oxyhydroxide | Sucroferric oxyhydroxide | Tablet, chewable, 2.5 g (equivalent to 500 mg iron) | sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 | Velphoro | HS | 10230K | S | N | N | ORAL | 2 | 180 | 5 | 497 | VL | 90 | 90 | N | 340 | 340 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10231L_16174_1314_5750_36622 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg | desvenlafaxine 100 mg modified release tablet, 28 | Desfax | GE | 10231L | R | N | Y | ORAL | 1 | 28 | 5 | 142 | AF | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10231L_16174_1314_5750_41176 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg | desvenlafaxine 100 mg modified release tablet, 28 | Desvenlafaxine Sandoz | GE | 10231L | R | N | Y | ORAL | 1 | 28 | 5 | 90 | SZ | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2016-11-01 | N | N | 3,671 |
10231L_16174_1314_5750_41757 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg | desvenlafaxine 100 mg modified release tablet, 28 | DESVEN | GE | 10231L | R | N | Y | ORAL | 1 | 28 | 5 | 1,081 | RW | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2017-02-01 | N | N | 3,671 |
10231L_16174_1314_5750_58171 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg | desvenlafaxine 100 mg modified release tablet, 28 | BTC Desvenlafaxine | GE | 10231L | R | N | Y | ORAL | 1 | 28 | 5 | 90 | BG | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2024-07-01 | N | N | 3,671 |
10231L_16174_1314_5750_58639 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg | desvenlafaxine 100 mg modified release tablet, 28 | DESVENLAFAXINE-WGR XR | GE | 10231L | R | N | Y | ORAL | 1 | 28 | 5 | 2,410 | WG | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2024-09-01 | N | N | 3,671 |
10232M_14792_33253_33256_33258 | Alemtuzumab | Alemtuzumab | Solution concentrate for I.V. infusion 12 mg in 1.2 mL | alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial | Lemtrada | HB | 10232M | S | N | Y | INJECTION | 3 | 3 | 0 | 42 | GZ | 1 | 1 | N | 10,283.09 | 10,283.09 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10233N_14992_34275_34278_34280 | Sucroferric oxyhydroxide | Sucroferric oxyhydroxide | Tablet, chewable, 2.5 g (equivalent to 500 mg iron) | sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 | Velphoro | HB | 10233N | S | N | N | ORAL | 2 | 180 | 5 | 497 | VL | 90 | 90 | N | 340 | 340 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10234P_16173_1314_5751_36620 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | desvenlafaxine 50 mg modified release tablet, 28 | Desvenlafaxine GH XR | GE | 10234P | R | N | Y | ORAL | 1 | 28 | 5 | 145 | GQ | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10234P_16173_1314_5751_39494 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | desvenlafaxine 50 mg modified release tablet, 28 | APO-Desvenlafaxine MR | GE | 10234P | R | N | Y | ORAL | 1 | 28 | 5 | 72 | TX | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2016-04-01 | N | N | 3,671 |
10238W_7398_1372_5888_7170 | Certolizumab pegol | Certolizumab pegol | Injection 200 mg in 1 mL single use pre-filled syringe | certolizumab pegol 200 mg/mL injection, 2 x 1 mL syringes | Cimzia | GE | 10238W | A | N | Y | INJECTION | 1 | 2 | 5 | 67 | UC | 2 | 2 | N | 952.13 | 952.13 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | N | Y | Y | null | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10241B_16175_1314_5751_36619 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg | desvenlafaxine 50 mg modified release tablet, 28 | Desfax | GE | 10241B | R | N | Y | ORAL | 1 | 28 | 5 | 142 | AF | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10241B_16175_1314_5751_41175 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg | desvenlafaxine 50 mg modified release tablet, 28 | Desvenlafaxine Sandoz | GE | 10241B | R | N | Y | ORAL | 1 | 28 | 5 | 90 | SZ | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2016-11-01 | N | N | 3,671 |
10241B_16175_1314_5751_41758 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg | desvenlafaxine 50 mg modified release tablet, 28 | DESVEN | GE | 10241B | R | N | Y | ORAL | 1 | 28 | 5 | 1,081 | RW | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2017-02-01 | N | N | 3,671 |
10241B_16175_1314_5751_58172 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg | desvenlafaxine 50 mg modified release tablet, 28 | BTC Desvenlafaxine | GE | 10241B | R | N | Y | ORAL | 1 | 28 | 5 | 90 | BG | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2024-07-01 | N | N | 3,671 |
10241B_16175_1314_5751_58640 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 50 mg | desvenlafaxine 50 mg modified release tablet, 28 | DESVENLAFAXINE-WGR XR | GE | 10241B | R | N | Y | ORAL | 1 | 28 | 5 | 2,410 | WG | 28 | 28 | N | 6.45 | 6.45 | N | 20 | Y | N | null | null | N | N | 16,220 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2024-09-01 | N | N | 3,671 |
10242C_10923_1315_5752_6991 | Sorafenib | Sorafenib | Tablet 200 mg (as tosilate) | sorafenib 200 mg tablet, 60 | Nexavar | GE | 10242C | S | N | Y | ORAL | 2 | 120 | 5 | 30 | BN | 60 | 60 | N | 1,993.7 | 1,993.7 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10243D_14792_33253_33256_33258 | Alemtuzumab | Alemtuzumab | Solution concentrate for I.V. infusion 12 mg in 1.2 mL | alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial | Lemtrada | HS | 10243D | S | N | Y | INJECTION | 5 | 5 | 0 | 42 | GZ | 1 | 1 | N | 10,283.09 | 10,283.09 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10245F_16172_1314_5750_36623 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | desvenlafaxine 100 mg modified release tablet, 28 | Desvenlafaxine GH XR | GE | 10245F | R | N | Y | ORAL | 1 | 28 | 5 | 145 | GQ | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10245F_16172_1314_5750_39495 | Desvenlafaxine | Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | desvenlafaxine 100 mg modified release tablet, 28 | APO-Desvenlafaxine MR | GE | 10245F | R | N | Y | ORAL | 1 | 28 | 5 | 72 | TX | 28 | 28 | N | 7.92 | 7.92 | N | 20 | Y | N | null | null | N | N | 16,219 | a | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2016-04-01 | N | N | 3,671 |
10246G_14792_33253_33256_33258 | Alemtuzumab | Alemtuzumab | Solution concentrate for I.V. infusion 12 mg in 1.2 mL | alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial | Lemtrada | HS | 10246G | S | N | Y | INJECTION | 3 | 3 | 0 | 42 | GZ | 1 | 1 | N | 10,283.09 | 10,283.09 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10250L_14992_34275_34278_34280 | Sucroferric oxyhydroxide | Sucroferric oxyhydroxide | Tablet, chewable, 2.5 g (equivalent to 500 mg iron) | sucroferric oxyhydroxide 2.5 g (iron 500 mg) chewable tablet, 90 | Velphoro | GE | 10250L | S | N | N | ORAL | 1 | 90 | 5 | 497 | VL | 90 | 90 | N | 340 | 340 | N | 4 | N | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10254Q_15375_414_34963_34965 | Mesalazine | Mesalazine | Sachet containing prolonged release granules, 4 g per sachet | mesalazine 4 g modified release granules, 30 sachets | Pentasa | GE | 10254Q | R | N | Y | ORAL | 1 | 30 | 5 | 133 | FP | 30 | 30 | N | 107.1 | 107.1 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-04-01 | N | N | 3,671 |
10257W_15374_414_35049_35051 | Mesalazine | Mesalazine | Sachet containing granules, 3 g per sachet | mesalazine 3 g modified release granules, 30 sachets | Salofalk | GE | 10257W | R | N | Y | ORAL | 1 | 30 | 5 | 1,688 | FD | 30 | 30 | N | 82.03 | 82.03 | N | 20 | Y | N | null | null | N | N | null | null | N | null | null | null | Y | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F2 | N | null | other | Y | N | N | N | N | null | null | null | null | null | null | 2015-05-01 | N | N | 3,671 |
10258X_15232_144_35302_35304 | amino acid formula with vitamins and minerals without phenylalanine | Amino acid formula with vitamins and minerals without phenylalanine | Sachets containing oral powder 36 g, 30 (PKU Anamix Junior) | amino acid formula with vitamins and minerals without phenylalanine oral liquid: powder for, 30 x 36 g sachets | PKU Anamix Junior | GE | 10258X | R | N | Y | ORAL | 4 | 4 | 5 | 152 | SB | 1 | 1 | N | 191.47 | 191.47 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10259Y_15233_145_35297_35299 | amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Amino acid formula with vitamins and minerals without valine, leucine and isoleucine | Sachets containing oral powder 36 g, 30 (MSUD Anamix Junior) | amino acid formula with vitamins and minerals without valine, leucine and isoleucine oral liquid: powder for, 30 x 36 g sachets | MSUD Anamix Junior | GE | 10259Y | R | N | Y | ORAL | 4 | 4 | 5 | 152 | SB | 1 | 1 | N | 399.63 | 399.63 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10260B_15234_770_35307_35309 | amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Amino acid formula with vitamins and minerals without phenylalanine and tyrosine | Sachets containing oral powder 36 g, 30 (TYR Anamix Junior) | amino acid formula with vitamins and minerals without phenylalanine and tyrosine oral liquid: powder for, 30 x 36 g sachets | TYR Anamix Junior | GE | 10260B | R | N | Y | ORAL | 4 | 4 | 5 | 152 | SB | 1 | 1 | N | 399.63 | 399.63 | N | 20 | N | N | null | null | N | N | null | null | N | null | null | null | N | Y | Y | Y | 4 | 6 | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10262D_10845_1272_5638_6832 | Cetuximab | Cetuximab | Solution for I.V. infusion 100 mg in 20 mL | cetuximab 100 mg/20 mL injection, 20 mL vial | Erbitux | IP | 10262D | S | N | Y | INJECTION | null | null | 18 | 105 | SG | 1 | 1 | N | 268.53 | 268.53 | Y | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 1,100 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10262D_8103_1272_5640_6834 | Cetuximab | Cetuximab | Solution for I.V. infusion 500 mg in 100 mL | cetuximab 500 mg/100 mL injection, 100 mL vial | Erbitux | IP | 10262D | S | N | Y | INJECTION | null | null | 18 | 105 | SG | 1 | 1 | N | 1,342.62 | 1,342.62 | Y | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 500 | 500 | Y | mg | N | N | 1,100 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10263E_11437_1200_5440_6553 | Anakinra | Anakinra | Injection 100 mg in 0.67 mL single use pre-filled syringe | anakinra 100 mg/0.67 mL injection, 28 x 0.67 mL syringes | Kineret | HS | 10263E | S | N | Y | INJECTION | 1 | 28 | 5 | 1,928 | ZO | 28 | 28 | N | 1,146.64 | 1,146.64 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10264F_11437_1200_5440_6553 | Anakinra | Anakinra | Injection 100 mg in 0.67 mL single use pre-filled syringe | anakinra 100 mg/0.67 mL injection, 28 x 0.67 mL syringes | Kineret | HB | 10264F | S | N | Y | INJECTION | 1 | 28 | 5 | 1,928 | ZO | 28 | 28 | N | 1,146.64 | 1,146.64 | N | 4 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | N | N | null | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10265G_10845_1272_5638_6832 | Cetuximab | Cetuximab | Solution for I.V. infusion 100 mg in 20 mL | cetuximab 100 mg/20 mL injection, 20 mL vial | Erbitux | IN | 10265G | S | N | Y | INJECTION | null | null | 18 | 105 | SG | 1 | 1 | N | 268.53 | 268.53 | Y | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 100 | 100 | Y | mg | N | N | 1,100 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10265G_8103_1272_5640_6834 | Cetuximab | Cetuximab | Solution for I.V. infusion 500 mg in 100 mL | cetuximab 500 mg/100 mL injection, 100 mL vial | Erbitux | IN | 10265G | S | N | Y | INJECTION | null | null | 18 | 105 | SG | 1 | 1 | N | 1,342.62 | 1,342.62 | Y | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | 500 | 500 | Y | mg | N | N | 1,100 | F1 | N | null | injectable | N | N | N | N | N | null | null | null | null | null | null | 2015-06-01 | N | N | 3,671 |
10266H_10876_857_4076_12413 | Zidovudine | Zidovudine | Capsule 100 mg | zidovudine 100 mg capsule, 100 | Retrovir | CA | 10266H | S | N | N | ORAL | 4 | 400 | 5 | 62 | VI | 100 | 100 | N | 129.81 | 129.81 | N | 20 | N | N | null | null | Y | N | null | null | N | null | null | null | Y | N | N | Y | null | null | 12 | 12 | 12 | null | null | N | null | Y | N | null | F1 | N | null | other | N | N | N | N | N | null | null | null | null | null | null | 2015-07-01 | N | N | 3,671 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.